Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Shineco ( (SISI) ) is now available.
On June 18, 2025, Shineco Life Science Group Hong Kong Co., Limited, a subsidiary of Shineco, Inc., completed the acquisition of 51% equity in InfiniClone Limited, a Hong Kong-based company. This strategic acquisition, valued at approximately $19.9 million in cash and 3,450,000 shares of Shineco’s common stock, positions Shineco Life Science to expand its operations and strengthen its market presence in the biotechnology sector.
More about Shineco
Shineco, Inc. operates in the life sciences industry through its subsidiary Shineco Life Science Group Hong Kong Co., Limited, focusing on biotechnology and related services.
Average Trading Volume: 1,493,443
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.64M
See more data about SISI stock on TipRanks’ Stock Analysis page.